Testa G, Ermani M, Giaretta D, Pellegrini A, Paleari C
Riv Neurol. 1980 Jul-Aug;50(4):241-52.
Clinico-pharmacological evaluation on Carbamazepine serum levels was performed in a group of epileptic patients. CBZ (Carbamazepine) blood levels have been detected in a heterogeneous group of epileptic patients taking several other antiepileptic drugs. Patients in which there was a good reduction of epileptic seizures after CBZ was added, had a mean blood level of 4.2 plus or minus 1.4 microgram/ml. When Dyphenilhydantoine (DPH) and/or Phenobarbital (PB) were associated with CBZ they both decreased CBZ blood levels; on the contrary CBZ did not appear to modify DPH and PB blood levels.
对一组癫痫患者进行了卡马西平血药浓度的临床药理学评估。在一组服用其他几种抗癫痫药物的癫痫患者中检测到了卡马西平(CBZ)的血药浓度。在添加CBZ后癫痫发作得到明显缓解的患者中,平均血药浓度为4.2±1.4微克/毫升。当苯妥英钠(DPH)和/或苯巴比妥(PB)与CBZ联用时,它们都会降低CBZ的血药浓度;相反,CBZ似乎不会改变DPH和PB的血药浓度。